Abstract:Although rare cancers, ocular tumors are a threat to vision, quality of life, and potentially life expectancy of a patient. Ocular proton therapy (OPT) is a powerful tool for successfully treating this disease. The Particle Therapy Co-Operative Ocular Group) formulated an Evidence and Expert-Based Executive Summary of Current Practices and Future Developments in OPT: comparative dosimetric and clinical analysis with the different OPT systems is essential to set up planning guidelines, implement best practices, and establish benchmarks for eye preservation, vision, and quality of life measures. Contemporary prospective trials in select subsets of patients (eg, tumors near the optic disc and/or macula) may allow for dosimetric and clinical analysis between different radiation modalities and beamline systems to evaluate differences in radiation delivery and penumbra, and resultant tumor control, normal tissue complication rates, and overall clinical cost-effectiveness. To date, the combination of multimodal imaging (fundus photography, ultrasound, etc), ophthalmologist assessment, and clip surgery with radiation planning have been keys to successful treatment. Increased use of three-dimensional imaging (computed tomography/magnetic resonance imaging) is anticipated although its spatial resolution might be a limiting factor (eg, detection of flat diffuse tumor parts). Commercially produced ocular treatment-planning systems are under development and their future use is expected to expand across OPT centers. Future continuity of OPT will depend on the following: (1) maintaining and upgrading existing older dedicated low-energy facilities, (2) maintaining shared, degraded beamlines at large proton therapy centers, and (3) developing adapted gantry beams of sufficient quality to maintain the clinical benefits of sharp beam conformity. Option (1) potentially offers the sharpest beams, minimizing impact on healthy tissues, whereas (2) and (3) potentially offer the advantage of substantial long-term technical support and development as well as the introduction of new approaches. Significant patient throughputs and close cooperation between medical physics, ophthalmology, and radiation therapy, underpinned by mutual understanding, is crucial for a successful OPT service.

Proton radiotherapy facility for ocular tumors at the IFJ PAN in Kraków Poland

Investigations on physical and biological range uncertainties in Krakow proton beam therapy centre

Feasibility of the J-PET to monitor range of therapeutic proton beams

Proton radiographs using position-sensitive silicon detectors and high-resolution scintillators

Feasibility of the J-PET to monitor the range of therapeutic proton beams

Proton Therapy Adaptation of Perisinusoidal and Brain Areas in the Cyclotron Centre Bronowice in Krakow: A Dosimetric Analysis

Development of a dedicated beam forming system for material and bioscience research with high intensity, small field electron beam of LILLYPUT 3 accelerator at Wroclaw Technology Park

A facility for radiation hardness studies based on a medical cyclotron

PTCOG Ocular Statement: Expert Summary of Current Practices and Future Developments in Ocular Proton Therapy

Nuclear Emulsion Film Detectors for Proton Radiography: Design and Test of the First Prototype

Application of LiMgPO4 crystal for proton beam quality control in radiotherapy

Alanine/EPR dosimetry for mailed intercomparison at ocular proton therapy facilities-preliminary results for three centres for irradaitions at CCB IFJ PAN eyeline

Track structure modelling for ion radiotherapy

Development of a laser-driven proton accelerator for cancer therapy

Imaging with protons at MedAustron

A facility for radiation hardness studies based on the Bern medical cyclotron

Measurement of proton-induced radiation in animal tissue

Clinical Practice Vs. State-of-the-art Research and Future Visions: Report on the 4D Treatment Planning Workshop for Particle Therapy – Edition 2018 and 2019

Single proton LET characterization with the Timepix detector and artificial intelligence for advanced proton therapy treatment planning

Alanine Dosimeters for LET Measurement in Proton Radiotherapy

Commissioning a clinical proton pencil beam scanning beamline for pre-clinical ultra-high dose rate irradiations on a cyclotron-based system